Generic:
Ferric Carboxymaltose

Description:
Ferisen 500/10-IV is an intravenous infusion of Ferric Carboxymaltose, manufactured by Healthcare Pharmaceuticals Limited. This treatment replenishes iron reserves and helps to manage iron deficiency anemia, especially for those who are intolerant to oral iron.

Benefits:

• Effective in treating iron deficiency anemia
• Suitable for patients who cannot tolerate oral iron
• Replenishes iron reserves in hemoglobin, myoglobin, and enzymes
• Helps transport oxygen via hemoglobin

Ingredients:
Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron, combined with carboxymaltose.

Uses and Doses:
For patients over 50 kg: Administer 750 mg of Ferric Carboxymaltose in two doses, separated by at least seven days, not exceeding 1500 mg. For patients under 50 kg: Administer 15 mg/kg body weight in two doses. The treatment may be repeated if iron deficiency anemia reoccurs.

Side Effects:
Common side effects include hypersensitivity reactions, hypertension, nausea, dizziness, facial flushing, and reactions at the injection site. In rare cases, severe allergic reactions may occur.

How to Use:
Administer intravenously, either undiluted as a slow IV push or diluted in 0.9% Sodium Chloride. Monitor for hypersensitivity reactions during and after infusion.

Pregnancy & Lactation:
Classified as Pregnancy Category C. Although animal studies have shown potential risks, the benefits may outweigh the risks for pregnant women. Caution is advised during lactation.

Precautions and Warnings:
Monitor for hypersensitivity reactions during and after administration. Personnel should be available to manage severe allergic reactions. Monitor blood pressure as a transient rise may occur.

Safety Information:
Avoid extravasation, as it may cause brown discoloration. Do not administer to patients with known hypersensitivity to Ferric Carboxymaltose.

Indications:
Treats iron deficiency anemia in adults intolerant to or unresponsive to oral iron, as well as chronic renal disease patients not requiring dialysis.

Pharmacology:
Ferric Carboxymaltose is a colloidal iron hydroxide combined with carboxymaltose. It replenishes iron reserves and aids oxygen transportation via hemoglobin.

Therapeutic Class:
Parenteral Iron Preparations

Storage Conditions:
Store below 30°C. Do not freeze.

3 FAQ:

1. What is Ferric Carboxymaltose used for?
   Ferric Carboxymaltose treats iron deficiency anemia in adults intolerant to or unresponsive to oral iron.
2. How is Ferric Carboxymaltose administered?
   It is administered intravenously as a slow IV push or infusion.
3. Can Ferric Carboxymaltose be used during pregnancy?
   It is classified as Pregnancy Category C, meaning it should be used if the potential benefits outweigh the risks.

Disclaimer:
This product should be used under medical supervision. Always consult a healthcare professional before starting any new treatment, especially during pregnancy or breastfeeding.

Keywords: Iron deficiency, ferric carboxymaltose, IV iron therapy, anemia treatment, healthcare pharmaceuticals, infusion therapy, chronic renal disease, iron infusion, parenteral iron, elemental iron, slow IV push, iron reserves, hemoglobin, carboxymaltose, renal disease, iron hydroxide, iron deficiency anemia, iron therapy, intravenous infusion, anemia management.